Emergent BioSolutions (EBS) Misses Q3 EPS by 3c, FY Revenue Guidance Beats
Go back to Emergent BioSolutions (EBS) Misses Q3 EPS by 3c, FY Revenue Guidance Beats| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 6.76 -0.04 (0.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.80 | 52 Week High | $44.38 | |||
| Open | $6.80 | 52 Week Low | $24.47 | |||
| Day High | $6.90 | P/E | 338.00 | |||
| Day Low | $6.48 | EPS | $0.02 | |||
| Volume | 496,876 | |||||
